Industry Growth Insights published a new data on “Histone Deacetylase 6 Market”. The research report is titled “Histone Deacetylase 6 Market research by Types (Citarinostat, CKD-504, ACY-738, HG-3001, MPT-0B291, Ricolinostat, Others), By Applications (CNS Lymphoma, Colon Cancer, Huntington Disease, Inflammation, Others), By Players/Companies Celgene Corp, Chong Kun Dang Pharmaceutical Corp, Curis Inc, HitGen LTD, Kancera AB, Karus Therapeutics Ltd, Medivir AB, Merck & Co Inc, Millennium Pharmaceuticals Inc, OnKure Inc, Celgene Corp, Shuttle Pharmaceuticals LLC, Sigma-Tau SpA, SK Biopharmaceuticals Co Ltd”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Histone Deacetylase 6 Market Research Report
By Type
Citarinostat, CKD-504, ACY-738, HG-3001, MPT-0B291, Ricolinostat, Others
By Application
CNS Lymphoma, Colon Cancer, Huntington Disease, Inflammation, Others
By Companies
Celgene Corp, Chong Kun Dang Pharmaceutical Corp, Curis Inc, HitGen LTD, Kancera AB, Karus Therapeutics Ltd, Medivir AB, Merck & Co Inc, Millennium Pharmaceuticals Inc, OnKure Inc, Celgene Corp, Shuttle Pharmaceuticals LLC, Sigma-Tau SpA, SK Biopharmaceuticals Co Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
162
Number of Tables & Figures
114
Customization Available
Yes, the report can be customized as per your need.
Global Histone Deacetylase 6 Market Report Segments:
The global Histone Deacetylase 6 market is segmented on the basis of:
Types
Citarinostat, CKD-504, ACY-738, HG-3001, MPT-0B291, Ricolinostat, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
CNS Lymphoma, Colon Cancer, Huntington Disease, Inflammation, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Celgene Corp
- Chong Kun Dang Pharmaceutical Corp
- Curis Inc
- HitGen LTD
- Kancera AB
- Karus Therapeutics Ltd
- Medivir AB
- Merck & Co Inc
- Millennium Pharmaceuticals Inc
- OnKure Inc
- Celgene Corp
- Shuttle Pharmaceuticals LLC
- Sigma-Tau SpA
- SK Biopharmaceuticals Co Ltd
Highlights of The Histone Deacetylase 6 Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Citarinostat
- CKD-504
- ACY-738
- HG-3001
- MPT-0B291
- Ricolinostat
- Others
- By Application:
- CNS Lymphoma
- Colon Cancer
- Huntington Disease
- Inflammation
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Histone Deacetylase 6 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Histone deacetylase 6 (HDAC6) is an enzyme that catalyzes the chemical reaction of acetyl groups with lysine residues in histones. This process results in the removal of acetyl groups from histones, which can lead to a decrease in their stability and transcriptional activity. HDAC6 is implicated in a variety of diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.
Some of the major players in the histone deacetylase 6 market are Celgene Corp, Chong Kun Dang Pharmaceutical Corp, Curis Inc, HitGen LTD, Kancera AB, Karus Therapeutics Ltd, Medivir AB, Merck & Co Inc, Millennium Pharmaceuticals Inc, OnKure Inc, Celgene Corp, Shuttle Pharmaceuticals LLC, Sigma-Tau SpA, SK Biopharmaceuticals Co Ltd.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Histone Deacetylase 6 Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Histone Deacetylase 6 Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Histone Deacetylase 6 Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Histone Deacetylase 6 Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Histone Deacetylase 6 Market Size & Forecast, 2020-2028
4.5.1 Histone Deacetylase 6 Market Size and Y-o-Y Growth
4.5.2 Histone Deacetylase 6 Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Citarinostat
5.2.2 CKD-504
5.2.3 ACY-738
5.2.4 HG-3001
5.2.5 MPT-0B291
5.2.6 Ricolinostat
5.2.7 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 CNS Lymphoma
6.2.2 Colon Cancer
6.2.3 Huntington Disease
6.2.4 Inflammation
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Histone Deacetylase 6 Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Histone Deacetylase 6 Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Citarinostat
9.6.2 CKD-504
9.6.3 ACY-738
9.6.4 HG-3001
9.6.5 MPT-0B291
9.6.6 Ricolinostat
9.6.7 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 CNS Lymphoma
9.10.2 Colon Cancer
9.10.3 Huntington Disease
9.10.4 Inflammation
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Citarinostat
10.6.2 CKD-504
10.6.3 ACY-738
10.6.4 HG-3001
10.6.5 MPT-0B291
10.6.6 Ricolinostat
10.6.7 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 CNS Lymphoma
10.10.2 Colon Cancer
10.10.3 Huntington Disease
10.10.4 Inflammation
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Citarinostat
11.6.2 CKD-504
11.6.3 ACY-738
11.6.4 HG-3001
11.6.5 MPT-0B291
11.6.6 Ricolinostat
11.6.7 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 CNS Lymphoma
11.10.2 Colon Cancer
11.10.3 Huntington Disease
11.10.4 Inflammation
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Citarinostat
12.6.2 CKD-504
12.6.3 ACY-738
12.6.4 HG-3001
12.6.5 MPT-0B291
12.6.6 Ricolinostat
12.6.7 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 CNS Lymphoma
12.10.2 Colon Cancer
12.10.3 Huntington Disease
12.10.4 Inflammation
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Citarinostat
13.6.2 CKD-504
13.6.3 ACY-738
13.6.4 HG-3001
13.6.5 MPT-0B291
13.6.6 Ricolinostat
13.6.7 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 CNS Lymphoma
13.10.2 Colon Cancer
13.10.3 Huntington Disease
13.10.4 Inflammation
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Histone Deacetylase 6 Market: Competitive Dashboard
14.2 Global Histone Deacetylase 6 Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Celgene Corp
14.3.2 Chong Kun Dang Pharmaceutical Corp
14.3.3 Curis Inc
14.3.4 HitGen LTD
14.3.5 Kancera AB
14.3.6 Karus Therapeutics Ltd
14.3.7 Medivir AB
14.3.8 Merck & Co Inc
14.3.9 Millennium Pharmaceuticals Inc
14.3.10 OnKure Inc
14.3.11 Celgene Corp
14.3.12 Shuttle Pharmaceuticals LLC
14.3.13 Sigma-Tau SpA
14.3.14 SK Biopharmaceuticals Co Ltd
